









































Individual and Area-level Factors Contributing
to the Geographic Variation in Ambulatory
Care Sensitive Conditions in Finland
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Background: Measuring primary health care (PHC) performance
through hospitalizations for ambulatory care sensitive conditions
(ACSCs) remains controversial—recent cross-sectional research
claims that its geographic variation associates more with individual
socioeconomic position (SEP) and health status than PHC supply.
Objectives: To clarify the usage of ACSCs as a PHC performance
indicator by quantifying how disease burden, both PHC and hospital
supply and spatial access contribute over time to geographic variation
in Finland when individual SEP and comorbidities were adjusted for.
Methods: The Finnish Care Register for Health Care provided
hospitalizations for ACSCs (divided further into subgroups of acute,
chronic, and vaccine-preventable causes) in 2011–2017. With
3-level nested multilevel Poisson models—individuals, PHC au-
thorities, and hospital authorities—we estimated the proportion of
the variance in ACSCs explained by selected factors at 3 time pe-
riods.
Results: In age-adjusted and sex-adjusted analysis of total ACSCs the
variances between hospital authorities was nearly twice that between
PHC authorities. Individual SEP and comorbidities explained 19%–30%
of the variance between PHC authorities and 25%–36% between hos-
pital authorities; and area-level disease burden and arrangement and
usage of hospital care a further 14%–16% and 32%–33%—evening out
the unexplained variances between PHC and hospital authorities.
Conclusions: Alongside individual factors, areas’ disease burden
and factors related to hospital care explained the excess variances in
ACSCs captured by hospital authorities. Our consistent findings over
time suggest that the local strain on health care and the regional
arrangement of hospital services affect ACSCs—necessitating cau-
tion when comparing areas’ PHC performance through ACSCs.
Key Words: health services research, multilevel modelling, pre-
ventable hospitalizations, primary care
(Med Care 2021;59: 123–130)
Hospitalizations for ambulatory care sensitive conditions(ACSC) is among the most commonly used proxy in-
dicators to measure primary health care (PHC) performance.1
ACSCs have been suggested as potentially avoidable by well-
functioning PHC.2 As equity in delivery of health care can be
assessed by measuring geographic variation in different
medical practices,3 delivery of PHC can be assessed through
geographic variation in ACSCs. Variation in ACSC is a
common phenomenon,4 but it is driven more by individual
socioeconomic position (SEP) and health status than general
practitioner (GP) workload.5 Thus, the link between ACSCs
and PHC performance remains controversial (Table 1).
ACSCs seem to associate with increased health needs of
individuals.6,7 From the patients’ perspective ACSCs result from
nonadherence to treatment; for example, due to combined lack
of support and mental health issues.8 This helps to understand
why ACSCs are reduced by better patient support through
specified family physicians,9 payment models that reward
comprehensive care10 and continuity of care.11,12 However,
ACSC rates do not mirror the results of PHC clinical quality
indicators13—and their connection with the number of GPs re-
mains inconsistent.9,14
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Further, some individual and population characteristics
contributing to variation in ACSCs might be partially ad-
dressable by PHC policies. Although the individual socio-
economic gradient in ACSC rates disfavors the poorest, these
rates still differ depending on the incomes of residential areas.15
And while individual comorbidities are a major predictor of
ACSCs,16,17 even area-level disease prevalence explains var-
iation in ACSC rates.18 Shorter travel time to PHC reduces
ACSCs rates,9,19 while shorter travel time to hospitals,19 high
rurality,20 and high hospital bed supply12,21,22 increase them.
Few studies have assessed over time the devel-
opment of geographic distribution23,24 or variation in ACSC
rates,25,26 but describe these only with area-level factors.23,24
It is still unclear how a comprehensive array of area-
level factors over time contributes to geographic variation in
ACSCs, when individual SEP and health status are
adjusted for.
FINNISH CONTEXT
The mainly tax-funded Finnish health care system of-
fers a good framework to assess variation in ACSCs, com-
prising universal access, hierarchical structure and a long
tradition of collecting individual hospitalization data. Finland
has a strong public PHC where GPs operate as gatekeepers
to specialist care provided by public hospitals.27 PHC is
provided through ∼150 health centers,28 which act also
as community hospitals by providing inpatient care in GP
led wards. Hospital care is provided through 20 hospital
districts—each having mainly a single 24/7 emergency
hospital. An individual receives PHC services from a single
health center, which receives its specialist care through a
single hospital district. However, occupational and private
health care offer alternative routes to GP and specialist care
outpatient consultations.
TABLE 1. Glossary
ACSC Ambulatory care sensitive conditions
COPD Chronic obstructive pulmonary disease
GP General practitioner
ICD-10 International Classification of Diseases 10th revision
IRR Incidence rate ratio
MRR Median rate ratio
PHC Primary health care
PCV Proportional change in variance
SEP Socioeconomic position
TABLE 2. The Categories of Individual and Area-level Factors Added Into the Models Estimating the Geographic Variance of ACSCs
Added to Category Factors
Hypothesized Pathway for Risk
of ACSC Hospitalization Data Obtained From
Model 1 Individual
demographics
Age and sex Null model FOLK database maintained by
Statistics Finland
Model 2 Individual SEP
and health
status
Household incomes Lower SEP predisposes to material deprivation and
possibly to poorer care,30 for example through
communication mismatch with GPs31
FOLK database maintained by
Statistics Finland
Number of comorbidities Multimorbidity complicates treatments and associates
with acute diseases leading to hospitalizations32
The Care Register for Health Care
maintained by Finnish Institute of
Health and Welfare
Model 3 Area-level disease
burden
Proportion of population
aged ≥ 65 receiving
pensioner’s care
allowance (%)
Higher proportion of multimorbid elderly (with
limitations of activities in daily living) within
an area strain health care, possibly lowering the
threshold of hospital utilization
Statistical database Kelasto







occurring in GP led wards
of all ACSCs (%)
GP led wards are likely to have less constrictive
intake criteria than specialist care
Aggregated from the Care Register for
Health Care maintained by Finnish
Institute of Health and Welfare
Rate of hospital bed
utilization in specialist
health care






distance to health center
(km)
Long distance to health services might cause
delay and lead to disease exacerbation
Road and street network data
provided by both Esri Finland and









Number of GPs per 1000
inhabitants
Fewer GPs represent poorer availability of care General Practitioner survey provided
by Finnish Medical Association
Income median (€) Area’s wealth might affect the care of
multimorbid patients,35 differences in
provision of primary care15
Aggregated from the FOLK database
maintained by Statistics Finland
The subsequent models include all factors from the previous ones. All area-level factors were allocated to health center areas.
ACSC indicates ambulatory care sensitive conditions; GP, general practitioner; SEP, socioeconomic position.
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METHODS
Outcome Variable
The Finnish Care Register for Health Care provided in-
dividual hospitalizations for the total Finnish population aged
20 years or more in 2011–2017. Of these we identified ACSCs
using the UK definition29—with an addition of unspecified
pneumonia (ICD-10 diagnosis code J18.9) as used previously in
Finland.23 Further, we divided ACSCs into subgroups of acute,
chronic, and vaccine-preventable (Supplemental Digital Con-
tent 1, http://links.lww.com/MLR/C130). Competent authorities
linked hospitalization data into individual sociodemographic
data. We formed annual cohorts and applied municipality of
residence to allocate individuals into health center areas ac-
cording to arrangement of PHC; and into hospital districts ac-
cording to arrangement of hospital care. To account for hospital
















Total study population 4,203,024 2.5 4,254,995 2.5 4,388,766 2.6
Age (y)
20–54 1,449,327 0.6 1,474,922 0.6 1,573,093 0.6
55–64 1,463,115 1.1 1,428,219 1.0 1,403,760 1.0
65–74 672,900 2.6 708,863 2.5 739,912 2.5
75–84 392,232 6.1 406,370 5.8 426,180 5.8
85+ 225,450 15.9 236,621 15.6 245,821 16.2
Sex
Males 2,043,104 2.6 2,071,126 2.5 2,143,146 2.7
Females 2,159,920 2.4 2,183,869 2.4 2,245,620 2.5
Income
Quintile 1 855,827 4.7 865,091 4.5 904,007 4.4
Quintile 2 812,472 3.9 824,835 3.8 845,825 4.1
Quintile 3 803,963 2.1 815,350 2.0 842,794 2.3
Quintile 4 836,117 1.3 845,743 1.3 870,886 1.4
Quintile 5 894,479 0.9 903,808 0.9 925,084 0.9
No. comorbidities
0 3,829,145 1.3 3,853,135 1.2 3,961,902 1.3
1 285,115 10.5 301,763 9.8 316,921 9.8
2 74,391 23.8 84,120 22.5 92,130 22.4
3+ 14,373 54.7 15,977 52.6 17,813 55.4
Proportion of population aged ≥ 65 receiving pensioner’s care allowance (%)
Tercile 1 8.3–16.7 1,763,672 1.9 9.0–15.8 1,827,338 1.9 8.1–14.6 1,877,242 2.0
Tercile 2 16.8–19.5 1,562,636 2.7 15.9–18.5 1,550,841 2.6 14.7–17.5 1,664,597 2.7
Tercile 3 19.6–25.6 876,716 3.5 18.6–25.0 876,816 3.3 17.6–24.0 846,927 3.5
Proportion of ACSCs occurring in GP led wards of all ACSCs (%)
Tercile 1 32.9–25.4 1,842,453 2.3 1.1–29.7 1,953,356 2.3 0.5–26.8 2,454,779 2.2
Tercile 2 25.5–41.2 1,162,415 2.6 29.8–42.5 1,581,758 2.2 26.9–45.3 1,016,471 2.9
Tercile 3 41.3–72.9 1,198,156 2.8 42.6–73.7 719,881 3.4 45.4–73.2 917,516 3.3
Rate of hospital bed utilization in specialist health care
Tercile 1 0.13–0.23 2,395,000 2.0 0.14–0.22 2,362,852 1.9 0.14–0.21 2,400,369 2.0
Tercile 2 0.24–0.28 1,204,534 3.0 0.23–0.27 1,329,090 2.8 0.22–0.26 1,285,578 2.9
Tercile 3 0.29–0.39 603,490 3.9 0.28–0.41 563,053 3.9 0.27–0.48 702,819 3.9
Populations’ average distance to health center (km)
Tercile 1 1.2–4.7 2,374,959 2.1 1.2–4.6 2,410,214 2.0 1.2–4.8 2,517,459 2.1
Tercile 2 4.8–6.6 1,070,273 3.0 4.7–6.6 1,039,132 2.9 4.8–6.6 1,026,532 3.0
Tercile 3 6.7–26.4 757,792 3.4 6.7–26.8 805,649 3.2 6.7–26.9 844,775 3.3
Populations’ average distance to emergency hospital (km)
Tercile 1 2.8–20.8 2,673,218 2.2 2.8–21.1 2,741,170 2.1 2.8–21.8 2,900,462 2.3
Tercile 2 20.9–45.8 957,014 2.7 21.2–45.8 948,449 2.6 21.9–51.3 941,334 2.6
Tercile 3 45.9–331.1 572,792 3.9 45.9–331.1 565,376 3.8 51.4–331.1 546,970 3.9
No. GPs per 1000 inhabitants
Tercile 1 (median)* 0.58 2,281,069 2.3 0.61 2,500,773 2.2 0.59 2,803,283 2.3
Tercile 2 (median)* 0.71 1,265,989 2.7 0.74 932,620 2.8 0.74 877,856 2.8
Tercile 3 (median)* 0.82 655,966 3.2 0.84 821,602 3.0 0.85 707,627 3.4
Income median (€)
Tercile 1 17,900–20,600 772,433 3.7 19,000–21,900 722,894 3.6 20,000–22,800 868,618 3.4
Tercile 2 20,700–22,200 1,695,028 2.6 22,000–23,700 1,767,878 2.6 22,800–24,400 1,695,119 2.8
Tercile 3 22,300–36,800 1,735,563 1.9 23,800–38,600 1,764,223 1.8 24,500–40,600 1,825,029 2.0
*We had no permission to report the range for number of GPs acquired from the General Practitioner survey.
ACSC indicates ambulatory care sensitive conditions; GP, general practitioner.
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transfers we combined hospitalizations that occurred within
1 day of each other.
With these cohorts we asked: (1) how geographic var-
iance in ACSCs was distributed between PHC and hospital
care; (2) which factors predicted ACSCs; (3) which area-level
factors explained variance in ACSCs when analyzed sepa-
rately; (4) what were the relative proportions of variance
explained by area-level factors after adjustment for individual
factors; and (5) how the heterogeneity in risk of ACSCs de-
veloped with each added factor?
Individual Factors
The annual FOLK databases provided data for sex, age,
municipality of residence, and household income for each
individual with ACSCs. For these individuals we selected 5
comorbidities [chronic heart failure, chronic obstructive
pulmonary disease (COPD), diabetes, hypertension, and de-
mentia] as suggested by Saver et al16 from inpatient hospi-
talizations and specialist outpatient visits during the previous
5 years.
Area-level Factors
We chose area-level factors previously suggested to
affect ACSCs, such as disease prevalence18 and hospital
supply.12 These factors were allocated to health center areas
and further categorized for the purposes of reporting—as
summarized in Table 2. We categorized the proportion of the
population aged 65 and above receiving pensioner’s care
allowance as disease burden because it captures both disease
prevalence and functional limitations. It is granted when a
chronic disease or disability limits daily living activities.
Statistical Methods
Age-standardized rates were calculated using the direct
standardization.36 We built on the analysis strategy presented by
Falster et al5 and allocated the annual cohorts to 3-level Poisson
multilevel models: individuals were nested within 131 health
center areas, which were in turn nested within 20 hospital
districts. We analyzed separate models for total ACSCs and each
of the 3 ACSC subgroups in 3 consecutive time periods:
2011–2012, 2013–2014, and 2015–2017. The total Finnish
population of comparable age was applied as the population at
risk and added into the models as an offset (range, 4020–519,853
in health centers and 22,410–1,288,747 in hospital districts).
By first analyzing an age-adjusted and sex-adjusted
model (model 1) we estimated the random parameters (σ2)
representing the variance at health center and hospital district
levels to which we compared all subsequent models. We
added the factors stepwise into the models; and measured the
effects of each addition with the proportional change in var-
iance (PCV).37 To analyze which factors predicted ACSCs
we calculated incidence rate ratios (IRR). Finally, we calcu-
lated the areas’ heterogeneity in risk of ACSCs with median
rate ratios.38 The statistical analyses were performed with R,
release versions 3.5.139—using the Laplace approximation
method.40
TABLE 4. IRRs of Individual and Area-level Factors Significantly Associated With Total ACSCs and ACSC Subgroups in Finland in
2015–2017; From the Multilevel Poisson Models Adjusted Simultaneously for All Individual and Area-level Factors (Model 6)
Total Acute Chronic Vaccine-preventable
Variables IRR (95% CI) P IRR (95% CI) P IRR (95% CI) P IRR (95% CI) P
Sex
Male 1.00 1.00 1.00 1.00
Female 0.74 (0.73–0.74) < 0.001 0.95 (0.93–0.96) < 0.001 0.75 (0.74–0.76) < 0.001 0.60 (0.59–0.61) < 0.001
Age (y)
20–54 1.00 1.00 1.00 1.00
55–64 1.77 (1.74–1.80) < 0.001 1.11 (1.08–1.14) < 0.001 3.73 (3.59–3.88) < 0.001 2.16 (2.09–2.22) < 0.001
65–74 3.58 (3.52–3.63) < 0.001 1.66 (1.62–1.70) < 0.001 8.95 (8.62–9.29) < 0.001 4.88 (4.74–5.02) < 0.001
75–84 6.28 (6.18–6.37) < 0.001 2.47 (2.41–2.53) < 0.001 16.12 (15.54–16.73) < 0.001 9.20 (8.95–9.46) < 0.001
85+ 12.06 (11.88–12.25) < 0.001 4.71 (4.60–4.83) < 0.001 28.69 (27.66–29.77) < 0.001 19.66 (19.13–20.21) < 0.001
Income quintile
Lowest 1.00 1.00 1.00 1.00
2 0.78 (0.77–0.78) < 0.001 0.74 (0.72–0.75) < 0.001 0.77 (0.76–0.78) < 0.001 0.80 (0.79–0.82) < 0.001
3 0.65 (0.64–0.65) < 0.001 0.63 (0.61–0.64) < 0.001 0.62 (0.61–0.63) < 0.001 0.69 (0.67–0.70) < 0.001
4 0.54 (0.53–0.55) < 0.001 0.53 (0.51–0.54) < 0.001 0.50 (0.49–0.51) < 0.001 0.59 (0.58–0.60) < 0.001
Highest 0.43 (0.43–0.44) < 0.001 0.44 (0.43–0.45) < 0.001 0.38 (0.37–0.39) < 0.001 0.48 (0.47–0.49) < 0.001
No. comorbidities: 0–5 (+1
comorbidity)
2.33 (2.32–2.33) < 0.001 1.89 (1.88–1.91) < 0.001 2.80 (2.79–2.81) < 0.001 2.01 (2.00–2.02) < 0.001
Proportion of population aged 65+
receiving pensioner’s care
allowance (+1 SD)
1.06 (1.02–1.11) 0.008 1.12 (1.05–1.19) < 0.001 1.00 (0.95–1.06) 0.867 1.09 (1.04–1.15) 0.001
Proportion of ACSCs occurring
in GP led wards of all ACSC
hospitalizations (+1 SD)
1.03 (1.00–1.07) 0.024 1.01 (0.97–1.05) 0.622 1.04 (1.00–1.07) 0.060 1.06 (1.02–1.10) 0.002
Rate of hospital bed utilization in
specialist health care (+1 SD)
1.08 (1.04–1.12) < 0.001 1.08 (1.03–1.14) 0.002 1.12 (1.07–1.17) < 0.001 1.02 (0.98–1.07) 0.325
Income median (+1 SD) 1.07 (1.03–1.11) 0.001 1.10 (1.05–1.16) < 0.001 1.05 (1.01–1.10) 0.029 1.06 (1.01–1.11) 0.020
The IRR of area-level distances to health services and number of GPs did not significantly associate with ACSCs. Over time all these associations were stable as shown in
Supplementary Digital Content 1 (http://links.lww.com/MLR/C130). A bold font indicate statistically significant P values.
ACSC indicates ambulatory care sensitive conditions; CI, confidence interval; GP, general practitioner; IRR, incidence rate ratios.
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TABLE 5. Variance in Age-adjusted and Sex-adjusted Model (Model 1) in Total ACSCs and ACSC Subgroups Between HC Areas and HD in Finland at 3 Consecutive
Time Periods
2011–2012 2013–2014 2015–2017
HC HD HC HD HC HD
Models σ2 PCV (%) MRR σ2 PCV (%) MRR σ2 PCV (%) MRR σ2 PCV (%) MRR σ2 PCV (%) MRR σ2 PCV (%) MRR
Total ACSCs
Model 1 0.023 — 1.16 0.050 — 1.24 0.020 — 1.14 0.034 — 1.19 0.019 — 1.14 0.037 — 1.20
Model 2 0.016 29.9 1.13 0.032 35.7 1.19 0.014 27.9 1.12 0.026 24.6 1.16 0.016 18.7 1.13 0.025 31.0 1.16
Model 3 0.014 37.3 1.12 0.018 63.3 1.14 0.013 35.2 1.11 0.018 46.5 1.14 0.015 21.7 1.12 0.019 48.3 1.14
Model 4 0.013 44.0 1.11 0.016 68.1 1.13 0.011 44.1 1.10 0.014 57.3 1.12 0.013 34.3 1.11 0.013 64.0 1.12
Model 5 0.013 45.6 1.11 0.017 66.6 1.13 0.011 44.7 1.10 0.015 54.8 1.13 0.013 34.5 1.11 0.013 63.3 1.12
Model 6 0.011 52.1 1.11 0.013 74.2 1.11 0.010 47.5 1.10 0.013 61.1 1.12 0.012 39.8 1.11 0.012 67.4 1.11
Acute ACSCs
Model 1 0.027 — 1.17 0.038 — 1.21 0.025 — 1.16 0.035 — 1.20 0.026 — 1.17 0.055 — 1.25
Model 2 0.027 0.2 1.17 0.029 24.2 1.18 0.022 9.6 1.15 0.026 25.9 1.17 0.024 8.1 1.16 0.041 26.2 1.21
Model 3 0.027 0.8 1.17 0.018 52.9 1.14 0.022 11.8 1.15 0.016 53.6 1.13 0.023 10.8 1.16 0.029 46.8 1.18
Model 4 0.026 3.8 1.17 0.017 56.8 1.13 0.021 16.0 1.15 0.013 62.4 1.12 0.022 12.7 1.15 0.023 59.0 1.15
Model 5 0.025 6.7 1.16 0.017 57.0 1.13 0.020 17.8 1.15 0.012 65.6 1.12 0.022 13.4 1.15 0.022 59.5 1.15
Model 6 0.021 21.5 1.15 0.013 66.1 1.11 0.019 21.8 1.14 0.010 71.4 1.10 0.020 22.7 1.14 0.019 65.7 1.14
Chronic ACSCs
Model 1 0.034 — 1.19 0.072 — 1.29 0.029 — 1.18 0.055 — 1.25 0.027 — 1.17 0.035 — 1.20
Model 2 0.024 28.9 1.16 0.049 32.6 1.23 0.025 13.4 1.16 0.044 21.5 1.22 0.023 13.9 1.16 0.026 27.6 1.16
Model 3 0.023 31.8 1.16 0.033 55.0 1.19 0.025 14.9 1.16 0.035 36.7 1.20 0.023 13.3 1.16 0.022 38.5 1.15
Model 4 0.020 41.9 1.14 0.027 63.1 1.17 0.021 29.7 1.15 0.026 53.3 1.17 0.018 34.7 1.13 0.016 55.3 1.13
Model 5 0.019 44.3 1.14 0.030 57.9 1.18 0.020 32.0 1.14 0.030 46.7 1.18 0.017 36.2 1.13 0.017 51.4 1.13
Model 6 0.018 45.6 1.14 0.028 61.4 1.17 0.020 32.3 1.14 0.027 51.2 1.17 0.017 38.5 1.13 0.016 53.5 1.13
Vaccine-preventable ACSCs
Model 1 0.024 — 1.16 0.033 — 1.19 0.026 — 1.17 0.021 — 1.15 0.024 — 1.16 0.037 — 1.20
Model 2 0.018 25.9 1.14 0.026 20.1 1.17 0.020 26.1 1.14 0.021 1.4 1.15 0.021 13.1 1.15 0.032 14.8 1.18
Model 3 0.014 43.0 1.12 0.019 42.2 1.14 0.016 40.1 1.13 0.019 9.6 1.14 0.020 19.9 1.14 0.026 31.0 1.16
Model 4 0.013 46.4 1.11 0.017 47.4 1.13 0.015 44.0 1.12 0.018 15.0 1.14 0.018 28.4 1.13 0.020 45.9 1.14
Model 5 0.013 46.6 1.11 0.017 48.7 1.13 0.015 44.1 1.12 0.018 15.2 1.14 0.018 28.4 1.13 0.020 46.0 1.14
Model 6 0.011 52.9 1.11 0.015 56.1 1.12 0.014 48.9 1.12 0.016 21.1 1.13 0.017 31.8 1.13 0.019 48.8 1.14
Each subsequent model builds on the previous one and adds a category of explanatory factors: individual socioeconomic position and health status (model 2), area-level disease burden (model 3), area-level arrangement and usage
of hospital care (model 4), area-level distance to health services (model 5), and other area-level factors related to health services (model 6).


















































We observed 729,008 ACSCs in Finland in 2011–2017
(Table 3). The age-standardized ACSC rate in the adult
population decreased from 2.67 (95% confidence interval,
2.66–2.68) per 100 person-years in 2011–2012 to 2.57
(2.56–2.58) in 2015–2017. In the age-adjusted and sex-ad-
justed models—model 1—of total ACSCs the hospital district
level variance was approximately twice that of the health
center level. These variances decreased slightly over time at
both area levels, although the decrease was more pronounced
at hospital district level.
In the final models (model 6) male sex, higher age,
lower income, and higher number of comorbidities associated
with higher IRRs in total ACSCs and all ACSC subgroups
(Table 4). Area-level higher disease burden, hospital bed
utilization rate, and median income were associated with
higher IRRs in total ACSCs in all time periods—but a higher
proportion of ACSCs in GP led wards only in 2013–2014
(Supplemental Digital Content 1, http://links.lww.com/MLR/
C130).
Each area-level factor explained variation in ACSCs
when analyzed separately (Supplemental Digital Content 1,
http://links.lww.com/MLR/C130). For total ACSCs our final
model explained a little less than half (PCV= 39.8%–52.1%)
the health center level variance and almost two thirds
(PCV= 61.1%–74.2%) the hospital district level variance.
The highest PCV occurred in 2011–2012 from when it de-
creased over time along with the variances in age-adjusted
and sex-adjusted models. Although individual SEP and health
status explained 18.7%–29.9% of health center level variance
and 24.6%–35.7% of hospital district level variance, a com-
bination of area-level disease burden and both arrangement
and usage of hospital care accounted for an additional 14.1%–
16.2% and 32.4%–33.0% of the respective variances. And
while the distance to health services and number of GPs did
not add much to the models, the areas’ median income ac-
counted for an additional 2.7%–6.5% and 4.2%–7.6% of
these variances. Areas had some heterogeneity in risk of
ACSCs which decreased with subsequent models (Table 5).
DISCUSSION
This study analyzed how individual and area-level
factors over time contributed to geographic variance in
ACSCs between 2 nested levels of health service providers in
Finland. Among total ACSCs our final models explained less
than half (PCV= 39.8%–52.1%) the variance between health
center areas and almost two thirds (PCV= 61.1%–74.2%)
between hospital districts. Even after adjusting for individual
SEP and health status, area-level disease burden and both
arrangement and usage of hospital care still explained 14.1%–
16.2% and 32.4%–33.0% of these variances. The proportions
explained were consistent over time. In age-adjusted and sex-
adjusted models hospital districts showed more variation than
health center areas—a disparity which evened out after ad-
justing for the studied factors. This suggest that variation in
age-standardized and sex-standardized ACSC rates could be
driven more by factors related to hospital services rather
than PHC.
Our findings support the previous studies stating that
variation in ACSCs reflects health status,5,16–18,41 SEP,5,12,15,21
and factors related to hospital care.12,19,21,42–44 However, this
study emphasized that these factors explained more of the
variance occurring in hospital district level than in health
center level.
The finding for area-level disease burden—a combi-
nation of disease prevalence and functional limitations—adds
to earlier knowledge.18 It explained additional variance in-
dependent of individual SEP and comorbidities. We suggest
caution when interpreting ACSC rates adjusted with only
disease prevalence—especially if this factor is used as a
proxy for individual health status. We had a few possible
hypotheses for this independent effect. At the hospital district
level, it might reflect either different admission criteria be-
tween hospitals or systematically insufficient capacity of PHC
to answer the high morbidity and disabilities. For health
centers, it might reflect inadequate response of PHC in some
areas; a possible link between ACSCs and PHC performance.
The finding that local GP led wards maintained varia-
tion in ACSCs was consistent with previous studies.42,43
Countries applying ACSC rates as PHC performance in-
dicators should consider if their arrangement of hospital care
affects these rates. ACSCs also reflected areas’ overall ten-
dency for hospital utilization, suggesting unnecessary use of
available hospital supply34 rather than different GP referral
practices.45 The effects of distances to health services and the
number of GPs were captured by other factors—such as the
arrangement of hospital care. Our finding that higher area-
level income predicted higher ACSCs contradicts the pre-
viously reported low ACSC rates in wealthy areas.15 These
lower rates might not reflect better performing PHC, but
rather other factors such as population’s favorable health
status.
Strengths and Limitations
The main strength of this study was that we were able
to apply nested multilevel Poisson model to distinguish
the variance in ACSCs between PHC and hospital care. Further,
the individual hospitalization data used are of good quality46—
and their comprehensive usage ensured the generalizability of
our results in Finnish context. The relative proportions will
differ when analyzed elsewhere, but the phenomena behind the
analyzed factors are transferrable internationally.
Our study was limited by the lack of individual-level
survey data to enrich the applied registers. Moreover, we did
not analyze the effect of alternative routes to physician con-
sultations in Finland: occupational and private health care—
but believe that including individual and area-level incomes
account for them. As the geographic diagnosis coverage in
Finnish Register of PHC visits was partial,47 we had to collect
individual comorbidities from both specialist care outpatient
visits and hospital discharges.
CONCLUSIONS
This study observed that administrative areas’ disease
burden and hospital care utilization patterns contributed to
geographic variation in ACSCs—potential links to PHC
performance. This followed adjusting ACSCs for individual
Satokangas et al Medical Care  Volume 59, Number 2, February 2021
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SEP and health status, as well as for the country-specific
arrangement of hospital care. Countries measuring PHC
performance with ACSC rates should (1) consider that these
rates might be driven more by hospital care than PHC; (2)
interpret prevalence adjusted rates with caution; and (3)
consider that the arrangement of their hospital care might
affect not only ACSC rates, but also other factors thought to
reflect only the provision of PHC services.
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